Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  DAIICHI SANKYO COMPANY, LIMITED    4568   JP3475350009

DAIICHI SANKYO COMPANY, LIMITED (4568)
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

DAIICHI S : Notice on Details of the Share Options

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/12/2011 | 10:20am CEST
For Immediate Release

Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, President and CEO

(Code no.: 4568, First Section of Tokyo, Osaka and Nagoya Stock Exchanges) Please address inquiries to Toshiaki Sai, Corporate Officer, Vice President, Corporate Communications Department

Telephone: +81-3-6225-1126

http://www.daiichisankyo.com/Notice on Details of the Share OptionsTOKYO, Japan (July 12, 2011) Daiichi Sankyo Company, Limited has announced that the subscription amount and other details of its No.5 share options were decided today. As previously announced, the Board of Directors had reached a decision on June 27, 2011 to issue the said share remuneration-type stock options (share options) to remunerate Directors (excluding Outside Directors) and Corporate Officers

1. Name of share options

Daiichi Sankyo Company, Limited No. 5 share options

2. Total number of share options

2,328 share options (100 shares per one share option) Breakdown

Six (6) Directors: 1,102 share options

Eighteen (18) Corporate Officers: 1,226 share options

3. Subscription amount for share options

111,200 yen per share option

(1,112 yen per share)

Reference

Date of Board of Directors resolution: June 27, 2011

###
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DAIICHI SANKYO COMPANY, LI
10:34aDAIICHI SANKYO : AstraZeneca and Daiichi Sankyo Launch Proton Pump Inhibitor Nex..
AQ
04/21VAXART : Announces $5 Million Inavir Revenue Milestone
AQ
04/19DAIICHI SANKYO : Patent Issued for Methods for Producing Optically Active Valeri..
AQ
04/19DAIICHI SANKYO : Reports Outline Clostridium difficile Study Findings from Daiic..
AQ
04/12DAIICHI SANKYO : and DarwinHealth Enter Exclusive Research Collaboration for Nov..
AQ
04/05DAIICHI SANKYO : Moves delhi hc to block sale of fortis to manipal
AQ
04/04DAIICHI SANKYO : Agrees to Modify the Terms of the Settlement Program for U.S. O..
AQ
04/03DAIICHI SANKYO : 65IB) 65IB Drugs, Pharmaceuticals and Hematology related produc..
AQ
04/03DAIICHI SANKYO : $311.9 Million Federal Contract Awarded to Daiichi Sankyo
AQ
04/02DAIICHI SANKYO : moves SEBI to block Fortis-Manipal deal
AQ
More news
News from SeekingAlpha
04/20Vaxart earns $5M milestone from Daiichi on Inavir sales 
04/04Daiichi teams up with DarwinHealth to identify new cancer targets 
03/23Alzheon Files To Raise $80 Million In U.S. IPO 
03/09Homology Medicines Files For U.S. IPO 
03/093 THINGS IN BIOTECH, MARCH 8 : A Tale Of 3 New Trials 
Financials ( JPY)
Sales 2018 952 B
EBIT 2018 -
Net income 2018 57 027 M
Finance 2018 338 B
Yield 2018 1,86%
P/E ratio 2018 41,65
P/E ratio 2019 39,98
EV / Sales 2018 2,45x
EV / Sales 2019 2,51x
Capitalization 2 664 B
Chart DAIICHI SANKYO COMPANY, LI
Duration : Period :
DAIICHI SANKYO COMPANY, LI Technical Analysis Chart | 4568 | JP3475350009 | 4-Traders
Technical analysis trends DAIICHI SANKYO COMPANY, LI
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 3 245  JPY
Spread / Average Target -14%
EPS Revisions
Managers
NameTitle
Joji Nakayama President, CEO & Representative Director
Kentaro Takamura IR Contact, Manager-Finance & Accounting
Glenn J. Gormley Senior Managing Executive Officer, Head-R&D
Masahiko Ohtsuki Executive Officer & Senior Manager-Research
Kazunori Hirokawa Representative Director, VP & GM-Administration
Sector and Competitors
1st jan.Capitalization (M$)
DAIICHI SANKYO COMPANY, LIMITED25.45%24 750
JOHNSON & JOHNSON-9.35%339 783
PFIZER1.13%217 897
NOVARTIS-7.67%204 972
ROCHE HOLDING LTD.-12.52%191 890
MERCK AND COMPANY4.55%158 571